Wilde GJS. Effects of mass media communications on health and safety habits: an
overview of issues and evidence. Addiction.1993;88:983-996.
Nattinger AB, Hoffmann RG, Shapiro R, Gottlieb MS, Goodwin JS. The limited effect of legislative mandates on medical practice: the
example of breast-conserving surgery. N Engl J Med.1996;335:1035-1040.
Beahrs OH. The medical history of President Ronald Reagan. J Am Coll Surg.1994;178:86-96.
Kolata G. Mastectomy seen as extreme treatment. New York Times.1987;137:19.
Wallis C. Was this operation necessary? doctors question the First Lady's mastectomy
Lewin T. Nancy Reagan defends her decision to have mastectomy. New York Times.1988;137:6.
Surveillance, Epidemiology and End Results (SEER) Program Special
Public Use Tape (1973-90). Bethesda, Md: National Cancer Institute, DCPC, Surveillance Program,
Cancer Statistics Branch; November 1993.
Area Resource File (1992). Rockville, Md: Office of Data Analysis and Management, Bureau of
Health Professions, US Dept of Health and Human Services; 1992.
Kreiger N. Overcoming the absence of socioeconomic data in medical records: validation
and application of a census-based methodology. Am J Public Health.1992;82:703-710.
Hospital Data by Geographic Area for Aged Medicare Beneficiaries:
Selected Diagnostic Groups, 1986. Baltimore, Md: Health Care Financing Administration; 1990. HCFA publication
Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for
breast cancer. N Engl J Med.1992;326:1102-1107.
Nattinger AB, Gottlieb MS, Hoffmann RG, Walker AP, Goodwin JS. Minimal increase in use of breast-conserving surgery from 1986-1990. Med Care.1996;34:479-489.
International Classification of Diseases, Ninth Revision, Clinical
Modification. Washington, DC: Public Health Service, US Dept of Health and Human
Michalski TA, Nattinger AB. The influence of black race and socioeconomic status on the use of
breast-conserving surgery in Medicare beneficiaries. Cancer.1997;79:314-319.
Kleinbaum DG. Logistic Regression. New York, NY: Springer-Verlag; 1994:73-86.
Helfenstein U. Box-Jenkins modelling in medical research. Stat Methods Med Res.1996;5:3-22.
Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the Surveillance, Epidemiology, and End Results
registry population: factors relevant to epidemiology and health care research. J Clin Epidemiol.1997;50:939-945.
Pollock III PH. Issues, values, and critical moments: did ‘Magic' Johnson transform
public opinion on AIDS? Am J Political Sci.1994;38:426-446.
Sumser J. Campus knowledge of AIDS before and after ‘Magic' Johnson announced
his infection. Sociol Soc Res.1992;76:182-184.
Whalen CK, Henker B, O'Neil R, Hollingshead J, Holman A, Moore B. Preadolescents' perceptions of AIDS before and after Earvin ‘Magic'
Johnson's announcement. J Pediatr Psychol.1994;19:3-17.
Langer LM, Zimmerman RS, Hendershot EF, Singh M. Effect of ‘Magic' Johnson's HIV status on HIV-related attitudes
and behaviors of an STD clinic population. AIDS Educ Prev.1992;4:295-307.
Lane DS, Polednak AP, Burg MA. The impact of media coverage of Nancy Reagan's experience on breast
cancer screening. Am J Public Health.1989;79:1551-1552.
Centers for Disease Control. Trends in screening mammograms for women 50 years of age and older—Behavioral
Risk Factor Surveillance System, 1987. MMWR Morb Mortal Wkly Rep.1989;38:137-140.
Fink R, Roeser R, Venet W, Strax P, Venet L, Lacher M. Effects of news events on response to a breast cancer screening program. Public Health Rep.1978;93:318-327.
Black MM, Leis Jr HP, Kwon CS. The breast cancer controversy: a natural experiment. JAMA.1977;237:970-971.
Greenburg ER, Stevens M. Recent trends in breast surgery in the United States and United Kingdom. Br Med J (Clin Res Ed).1986;292:1487-1491.
Brown M, Potosky A. The presidential effect: the public health response to media coverage
about Ronald Reagan's colon cancer episode. Public Opin Q.1990;54:317-329.
National Institutes of Health. Treatment of early-stage breast cancer [NIH Consensus Conference]. JAMA.1991;265:391-395.
Nayfield SG, Bongiovanni GC, Alciati MH, Fischer RA, Bergner L. Statutory requirements for disclosure of breast cancer treatment alternatives. J Natl Cancer Inst.1994;86:1202-1208.
Ganz PA. Treatment options for breast cancer—beyond survival. N Engl J Med.1992;326:1147-1149.